 |
 |

Chlamydia trachomatis and Cervical Neoplasia
Julius Schachter, PhD;
Edward C. Hill, MD;
Eileen B. King, MD;
David C. Heilbron, PhD;
Rose M. Ray, PhD;
Alan J. Margolis, MD;
Sadja A. Greenwood, MD
JAMA. 1982;248(17):2134-2138.
Abstract
 |  |
We tested 383 women with and 500 women without cervical neoplasia for antibodies against Chlamydia trachomatis or herpes simplex virus (HSV). Exposure to both agents was related to sexual activity, with the highest prevalence of antibodies found in women with more sex partners and who had first coitus at an earlier age. When subjects were matched for several risk factors (age, race, marital status, parity, number of sex partners, and history of venereal disease), a significant excess of antibodies against C trachomatis was found in cases as compared with control subjects (76.5% v 58.4%, respectively; n=149). Because matched-pair analysis lost a substantial proportion of women with neoplasia (largely because they were older), linear logistic analysis was performed. This also showed an excess of antichlamydial antibody in cases, with an estimated odds ratio of approximately 2 for the association of antichlamydial antibody and the risk of being a case. Neither analysis found an excess of antibodies to HSV type 2 in cases.
(JAMA 1982;248:2134-2138)
Author Affiliations
From the Departments of Laboratory Medicine (Dr Schachter), Obstetrics and Gynecology (Drs Hill, Margolis, and Greenwood), and Epidemiology and International Health (Dr King), and the Computer Center (Dr Heilbron), University of California, San Francisco.
Footnotes
Reprint requests to Department of Laboratory Medicine, University of California, San Francisco, CA 94143 (Dr Schachter).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
CHLAMYDIA TRACHOMATIS AND GENITAL HUMAN PAPILLOMAVIRUS INFECTIONS IN FEMALE UNIVERSITY STUDENTS IN HONDURAS
TABORA et al.
Am J Trop Med Hyg 2005;73:50-53.
ABSTRACT
| FULL TEXT
CADD, a Chlamydia Protein That Interacts with Death Receptors
Stenner-Liewen et al.
J. Biol. Chem. 2002;277:9633-9636.
ABSTRACT
| FULL TEXT
Combined screening for Chlamydia trachomatis and squamous intra-epithelial lesions using a single liquid-based cervical sample
Anguenot et al.
Hum Reprod 2001;16:2206-2210.
ABSTRACT
| FULL TEXT
Risks for Incident Human Papillomavirus Infection and Low-Grade Squamous Intraepithelial Lesion Development in Young Females
Moscicki et al.
JAMA 2001;285:2995-3002.
ABSTRACT
| FULL TEXT
Chlamydia trachomatis and cancer
Paavonen
Sex. Transm. Infect. 2001;77:154-156.
FULL TEXT
No association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia
Reesink-Peters et al.
Sex. Transm. Infect. 2001;77:101-102.
ABSTRACT
| FULL TEXT
Chlamydia and Cervical Cancer: A Real Association?
Zenilman
JAMA 2001;285:81-83.
FULL TEXT
Factors Associated With Human Papillomavirus Infection in Women Encountered in Community-Based Offices
Reed et al.
Arch Fam Med 1993;2:1239-1248.
ABSTRACT
Detection of Chlamydia Trachomatis in Adolescent Females Using Direct Immunofluorescence
Evans et al.
CLIN PEDIATR 1988;27:223-228.
ABSTRACT
Cytologic Manifestations of Cervical and Vaginal Infections: II. Confirmation of Chlamydia trachomatis Infection by Direct Immunofluorescence Using Monoclonal Antibodies
Kiviat et al.
JAMA 1985;253:997-1000.
ABSTRACT
|